Estimating Antimalarial Drug Consumption in Africa
Author Information
Author(s): Kindermans Jean-Marie, Vandenbergh Daniel, Vreeke Ed, Olliaro Piero, D'Altilia Jean-Pierre
Primary Institution: AEDES Foundation
Hypothesis
How can we accurately estimate the consumption of antimalarial drugs in Africa?
Conclusion
The study estimates that Africa's annual need for financing ACT procurement could range from US$ 113 million to US$ 566.1 million.
Supporting Evidence
- The study found that the number of adult treatments per capita in the five countries ranged from 0.18 to 0.50.
- Current adult treatment prices for ACTs range from US$ 1 to US$ 1.8.
- The highest estimated number of adult treatments consumed in Africa was 314.5 million.
Takeaway
This study looks at how much antimalarial medicine is used in Africa to help plan for future needs. It found that a lot of money is needed to buy these medicines.
Methodology
Data on drug consumption was collected from five sub-Saharan African countries through visits and interviews with supply chain stakeholders.
Potential Biases
Potential biases may arise from external factors affecting consumption and the choice of study countries based on epidemiological rather than statistical criteria.
Limitations
The study faced challenges in data collection, especially from the private sector, and the informal sector was not systematically analyzed.
Participant Demographics
Data were collected from five countries: Senegal, Rwanda, Tanzania, Malawi, and Zimbabwe, representing diverse geographical and epidemiological settings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website